{"publication_id":"060fa963-9582-4658-ad87-91a057301d4f","method_note":"Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.","sources":[{"study":"Comparative Effectiveness of CagriSegma , Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials","doi":"10.1002/edm2.70248","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials","doi":"10.1007/s00125-024-06144-1","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults","doi":"10.1038/s41591-025-03978-z","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study)","doi":"10.1186/s12902-024-01658-6","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach","doi":"10.1111/dom.70678","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis","doi":"10.1002/edm2.70136","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial","doi":"10.1002/oby.24222","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta analysis","doi":"10.5144/0256-4947.2025.129","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review","doi":"10.3390/ijms25084346","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis *","doi":"10.15605/jafes.037.02.14","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effectiveness and safety of once-weekly semaglutide: findings from the SEMACOL-REAL retrospective multicentric observational study in Colombia","doi":"10.3389/fendo.2024.1372992","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Disease-modifying effect, safety and optimal dose of oral semaglutide tablets for patients with Parkinson’s disease (MOST-ABLE study): protocol for a randomised, double-blind, placebo-controlled study","doi":"10.1136/bmjopen-2025-112318","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Gastrointestinal safety evaluation of semaglutide for the treatment of type 2 diabetes mellitus: A meta-analysis","doi":"10.1097/MD.0000000000038236","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression.","doi":"10.1111/dom.70667","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.","doi":"10.1016/j.amjcard.2024.04.041","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Studenski 2011","doi":"10.1001/jama.2010.1923","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Cesari 2009","doi":"10.1093/gerona/glp012","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Perera 2006","doi":"10.1111/j.1532-5415.2006.00701.x","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"ADA 2024","doi":"10.2337/dc24-S006","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"WHO 2000","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Bohannon 1997","doi":"10.1093/ageing/26.1.15","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Cruz-Jentoft 2019","doi":"10.1093/ageing/afy169","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Tinetti 1988","doi":"10.1056/NEJM198812293192604","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Tancredi 2015","doi":"10.1056/NEJMoa1504347","risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Ioannidis 2005","doi":"10.1371/journal.pmed.0020124","risk_of_bias":"not appraised in public sidecar","directness":"citation"}]}